EVAg

Extracted Human Mastadenovirus A DNA, Type 31.

Infectious cellculture supernatant of human Enterovirus B - Coxsackie B2

Purified RNA of Coronavirus strain "BetaCoV/Germany/BavPat1/2020 p.1" grown in cell culture. Dislaimer: Import permit maybe be needed in your country. If yes, please indicate so in your online enquiry.

Infectious cellculture supernatant of human 2019-nCoV

Purified RNA of SARS-Coronavirus strain Frankfurt 1, grown in cell culture. Dislaimer: Import permit maybe be needed in your country for the SARS-CoV full virus RNA. If yes, please indicate so in your online enquiry.

Plaque-purified infectious cellculture supernatant of Herbert virus strain C59-CI-2004

in vitro transcribed RNA for human Astro virus real time PCR

Target region of a specific Real time assay was amplified and cloned.

Plasmid for in vitro transcription that contains the 5`UTR region of an Aichi virus for 5`UTR-Leader region PCR assays published by Drexler et al, Emerg Infect Dis. 2011

Human Coronavirus 229E plasmid for in vitro transcription.

in vitro transcribed RNA for Human coronavirus 229E real time PCR

Live virus: Enterovirus B. This Enterovirus is preserved under Viral Storage Medium -80C.Tests for the presence of mycoplasmae were negative. To confirm its identity the virus has been partially sequenced.

Live virus: Human parainfluenzavirus 4. This virus is preserved under Viral Storage Medium -80C.Tests for the presence of mycoplasmae were negative. To confirm its identity the virus has been partially sequenced.

In vitro transcribed RNA for Wuhan coronavirus (2019-nCoV) real time (RT-)PCR targeting region of the E gene . Protocol and preliminary evaluation for this assays (Corman/Drosten 2020), as of Jan 13, 2020, available from: https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2 Ref: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045

In vitro transcribed RNA for Wuhan coronavirus (2019-nCoV) real time (RT-)PCR targeting region of the RdRP gene . Protocol and preliminary evaluation for this assays (Corman/Drosten 2020), as of Jan 13, 2020, available from: https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2 Ref: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045

Extracted RNA of Human parainfluenzavirus 4.

Extracted RNA of Human coronavirus 229E isolate HCoV-229E/BN1/GER/2015

in vitro transcribed RNA for Human coronavirus NL63 real time PCR

Extracted RNA of an Enterovirus B isolate.

In vitro transcribed RNA containing priming sites for different zika virus real time PCRs.

In vitro transcribed RNA that contains priming sites for different Zika virus rt-PCRs, encapsulated within a protective protein coat.

In vitro transcribed RNA for a specific SARS-coronavirus real time PCR.

Training in Coronavirus reverse genetics to adapt novel techniques (ISA method) to large RNA viruses and compare different technologies under BSL-3 conditions

The in vitro transcribed RNA is the control for the first-line screening assay termed E gene assay. The SARS-CoV full virus RNA is required to control the two confirmatory assays. Dislaimer: Import permit maybe be needed in your country for the SARS-CoV full virus RNA. If yes, please indicate so in your online enquiry.

SARS-CoV-2 diagnostic training, including differential diagnostics of human Coronaviruses and other respiratory pathogens, incl. BSL-2 and BLS-3 conditions.